ARTICLE | Clinical News
VIMRxyn: Phase I/II dose-ranging trial in Thailand
January 8, 1996 8:00 AM UTC
VIMRx Pharmaceuticals Inc. (VMRX), Stamford, Conn. Product: VIMRxyn, synthetic hypericin Indication: HIV Status: Began a Phase I/II dose-ranging trial in Thailand in 24 HIV-positive patients, with ora...